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Introduction: Outcome measures are key to tailor rehabilitation goals to the stroke
patient’s individual needs and to monitor poststroke recovery. The large number of
available outcome measures leads to high variability in clinical use. Currently, an
internationally agreed core set of motor outcome measures for clinical application is
lacking. Therefore, the goal was to develop such a set to serve as a quality standard
in clinical motor rehabilitation poststroke.
Methods: Outcome measures for the upper and lower extremities, and activities
of daily living (ADL)/stroke-specific outcomes were identified and presented to stroke
rehabilitation experts in an electronic Delphi study. In round 1, clinical feasibility and
relevance of the outcomemeasures were rated on a 7-point Likert scale. In round 2, those
rated at least as “relevant” and “feasible” were ranked within the body functions, activities,
and participation domains of the International Classification of Functioning, Disability, and
Health (ICF ). Furthermore, measurement time points poststroke were indicated. In round
3, answers were reviewed in reference to overall results to reach final consensus.
Results: In total, 119 outcome measures were presented to 33 experts from 18
countries. The recommended core set includes the Fugl–Meyer Motor Assessment
and Action Research Arm Test for the upper extremity section; the Fugl–Meyer Motor
Assessment, 10-m Walk Test, Timed-Up-and-Go, and Berg Balance Scale for the
lower extremity section; and the National Institutes of Health Stroke Scale, and Barthel
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Index or Functional Independence Measure for the ADL/stroke-specific section. The
Stroke Impact Scale was recommended spanning all ICF domains. Recommended
measurement time points are days 2± 1 and 7; weeks 2, 4, and 12; 6 months poststroke
and every following 6th month.
Discussion and Conclusion: Agreement was found upon a set of nine outcome
measures for application in clinical motor rehabilitation poststroke, with seven
measurement time points following the stages of poststroke recovery. This core set was
specifically developed for clinical practice and distinguishes itself from initiatives for stroke
rehabilitation research. The next challenge is to implement this clinical core set across
the full stroke care continuum with the aim to improve the transparency, comparability,
and quality of stroke rehabilitation at a regional, national, and international level.
Keywords: stroke, motor rehabilitation, clinical, outcome measures, Delphi study
INTRODUCTION
Despite the advances of primary and secondary prevention and
the availability of acute medical interventions, stroke remains the
second most common cause of disability worldwide (1). Because
of an aging population and increasing rates of stroke in younger
adults, the number of stroke cases is most likely to increase to
1.5 million cases by the year 2025 (2). In respect to resulting
challenges to national health systems and social economy, a
European Stroke Action Plan was formulated and includes the
domains primary prevention, organization of stroke services,
management of acute stroke, secondary prevention, rehabilitation,
evaluation of stroke outcome/quality assessment, and life after
stroke (3). As motor deficits due to stroke lead to limitations
in the performance of activities of daily living (ADL), reduced
societal participation, and a lower quality of life (4), outcome
measures (OMs) in the motor domain comprise a key role
in optimizing and monitoring attainable treatment goals and
providing transparency regarding the quality along the stroke
care continuum (5). An early and systematic administration of
OMs could have multiple benefits for clinicians and patients,
such as objective monitoring of the recovery process and the
facilitation of goal-oriented interprofessional collaboration, and
to support the stroke survivor’s education. Currently, a significant
number of OMs are available for different clinical settings and
stages poststroke (6). Consequently, there is a large variability in
clinical use, which hampers transparency and the comparability
of motor rehabilitation within and across countries.
Clinical guidelines for evidence-based practice regarding
stroke operate on a national level and lack international
consensus regarding the use of OMs and, more importantly,
the timing of measurements. Despite attempts of implementing
the evidence resulting from stroke rehabilitation research into
clinical stroke rehabilitation by specific clinical guidelines, the
adherence across Europe is often insufficient (7). Standards for
OMs to use are not commonly practiced, and the administration
of OMs in the field of stroke rehabilitation and other areas
is surprisingly low (8). Recently, an international group of
researchers systematically reviewed existing clinical guidelines
on recommendations for upper extremity assessments and
concluded that there is a lack of explicit recommendations on
OMs in most of the guidelines (9).
Specifically for research purposes, consensus-based
recommendations for sensorimotor measurements in stroke
rehabilitation trials were developed by the international
Stroke Recovery and Rehabilitation Roundtable (SRRR) to
set standards for methodological quality for clinical trials on
the body functions and activities domains of the International
Classification of Functioning, Disability, and Health (ICF) (10).
Also, local and national research groups recommended OMs
for stroke research (11–13), including specific interventions
such as robotics (14), a single poststroke recovery stage (15),
and patient-reported outcomes only (16, 17). Although these
efforts are very valuable for stroke rehabilitation research, the
recommendations cannot be translated one to one into clinical
practice, as the requirements on OMs for clinical use might
differ by aspects of the administration time, the number of
measurement time points, and the length of follow-up. It is also
likely that, for clinical practice, a broader spectrum in terms
of impairment and disability levels as well as body sections is
relevant, when compared to those covered by various research
initiatives. Furthermore, the clinical core set should incorporate
the patient’s multidomain perspective (18) that was not covered
by the SRRR research recommendations, and an international
group of clinical stakeholders should be involved.
Therefore, the aim of the present study was to develop
an international consensus-based core set of OMs with fixed
measurement time points for clinical use in motor rehabilitation
after stroke, which is relevant for the full stroke rehabilitation
pathway. This set is a key ingredient for transparent stroke
rehabilitation and allows alignment between regions and
countries with the ultimate goal to improve stroke patients’
motor outcomes.
MATERIALS AND METHODS
Identification of Outcome Measures
An initial collection of sensorimotor OMs was compiled based
on an extensive search in relevant systematic reviews (6, 10–27),
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clinical guidelines (28, 29), and electronic rehabilitation
measurement databases [e.g., StrokEngine (30) and Shirley Ryan
Ability Lab (31)] by two researchers (JP, JV). The OMs had
to meet the following inclusion criteria: (1) assess the motor
domain, (2) validated for use in stroke patients, and (3) have a
good reliability for the stroke population (intraclass correlation
coefficient > 0.7). Eligible OMs were allocated to one of the
following three sections: the upper extremity, lower extremity,
or ADL/stroke-specific section. The constructs of trunk control,
balance, and mobility were assigned to the lower extremity
section. The ADL/stroke-specific section included a broader
variety of constructs, assessing stroke-specific motor-related
functions, activities, and participation. Within each section, OMs
were classified according to the ICF domains body structure and
function, activities, and participation (18).
Delphi Study Design
A Delphi study design was used to develop the consensus-based
core set. The three-round Delphi study was conducted from
November 2018 until April 2019. Per section, we aimed to have
one OM in each ICF domain that could be applied, regardless of
stroke severity. In the lower extremity section, one OM per ICF
domain had to be applicable for both patients with and without
walking ability.
After each round, each expert received an individualized
feedback report with details of the previous round’s results in
reference to their personal rating. In round 1, each OM was
presented with details of the measure’s construct, costs, time
to administer, and clinimetric properties [validity, reliability,
and minimal clinically important difference (MCID)] in line
with COSMIN recommendations (Figure 1) (32). For each OM,
experts had to rate on a 7-point Likert scale: (1) how familiar
they were with that measure, (2) its relevance for clinical practice,
and (3) its clinical feasibility. The initial set of OMs was then
reduced to those, rated with scores of at least five of seven points
for both clinical relevance and clinical feasibility. In round 2, the
reduced set of OMs had to be prioritized for each section and
ICF domain by assigning ranks in ascending order. As for some
lower extremity OMs, patients need to be able to walk; a second
measure was allowed if the OM ranked first requires walking
ability. For each section, the highest-ranked OM within each
ICF domain was included in a preliminary core set for the third
round. Additionally, the experts designed a specific measurement
scheme, indicating their preferred measurement time points
poststroke: Within the acute phase (days 1, 3, and 7), early
subacute phase (weeks 2, 4, 6, and 10), the late subacute phase
(weeks 12, 16, and 20 and month 6) and for the chronic phase
(every 3rd and 6th month following). The minimal agreement
rate on measurement timing in round 2 was set to at least
50% ± 2%. In round 3, the experts reviewed the aggregated
results presented next to their individual rankings and suggested
time points and confirmed their agreement. The cutoff rate for
minimal agreement on measurement time points in round 3 was
70± 5%.
A clearance certificate for this study was provided by the
cantonal ethics committee Zurich (BASEC Nr. Req-2018-00601).
Informed consent of the participating experts was not needed.
Rehabilitation Experts
From September to October 2018, personal enquiries were sent
to renowned experts of stroke rehabilitation research and with a
networking approach via the following organizations: European
Stroke Organization, Council of Occupational Therapists
in European Countries, Research in Occupational Therapy
and Occupational Science, European Network Occupational
Therapy, and the European Network of Physiotherapy in
Higher Education. It was our goal to recruit a balanced group
of international experts with different clinical backgrounds,
including medical doctors, physical therapists, occupational
therapists, and rehabilitation engineers. Persons were considered
eligible if they had expertise in clinical stroke rehabilitation
and clinical research or rehabilitation engineering research and
hold at least a master of science degree. The experts were kept
ignorant about the other participating experts and received
no compensation.
Data Collection and Analysis
The participants received detailed information and instructions
on a website with access to the first round’s electronic survey
created with Research Electronic Data Capture (REDCap,
Vanderbilt University Medical Center, USA). Rounds 2 and 3
were carried out via personalized electronic forms, sent and
responded via email. Responses were filed by hand (JP) and cross-
checked for insertion errors (JH, JV). Feedback of results was
given after each round, and equivocal responses were followed
up by inquiries via email. Rankings and ratings were analyzed as
medians and interquartile ranges. The data were analyzed after
each round and presented for the next round. Data analysis and
visualization were conducted with Microsoft Office Professional
Plus 2016 (Microsoft Cooperation, Redmond, WA, USA).
RESULTS
Participants
Written inquiries yielded 46 eligible experts of whom 33 experts
from 18 countries participated and completed the first round of
the Delphi study with a response rate of 72% (Table 1). Final
agreement was given by 27 experts with three participants lost
after the first round and three after the second round.
Development of the Core Set for Clinical
Motor Rehabilitation After Stroke
In total, 177 OMs were identified, of which 119 met the inclusion
criteria and were presented to the experts. Fifty-nine OMs were
rated as being relevant and feasible and were consecutively
ranked in round 2. In round 3, final agreement for a core set of
nine OMs was given (Figure 2, Table 2).
The highest ranking in the upper extremity section was given
to the Upper Extremity Subscale of the Fugl–Meyer Motor
Assessment (FMA-UE) in the body functions domain and the
Action Research Arm Test (ARAT) for the activities domain.
In the lower extremity section, the two OMs with the highest
rankings in the body functions domain were the Fugl–Meyer
Motor Assessment Lower Extremity Subscale (FMA-LE) and
the 10-m Walk Test (10 MWT); for the activities domain, the
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FIGURE 1 | Overview of the Delphi process. ICF, International Classification of Functioning, Disability, and Health; OMs, outcome measures.
TABLE 1 | Participant characteristics.
Characteristic N = 33
Profession, n (%)
Medical doctor 12 (36.4)
Occupational therapist 8 (24.2)
Physical therapist 11 (33.3)
Rehabilitation engineer 2 (6.1)
Experience, Median (IQR), Years
Clinical 15 (9)
Research 15 (14)
Region of practice Austria, Belgium, Czech Republic,
Cyprus, Denmark, Finland,
Germany, Italy, Latvia, Lithuania,
the Netherlands, Norway, Poland,
Portugal, Spain, Sweden,
Switzerland, United Kingdom
IQR, interquartile range.
Timed-Up-and-Go (TUG) and the Berg Balance Scale (BBS) were
indicated. Regarding the ADL/stroke-specific section, the highest
ranks were given to the National Institutes of Health Stroke
Scale for the body functions domain, and the Barthel Index
(BI) or Functional Independent Measure (FIM) for the activities
domain. Within all sections, the Stroke Impact Scale (SIS) was
prioritized first for the participation domain. However, it should
be noted that the SIS also provides the patient’s perspective on
the body functions and activities domains of the ICF. Subsections
of the SIS (hand function, mobility, strength) were presented
separately for the upper extremity and lower extremity sections
and the whole SIS for the ADL/stroke-specific section. Detailed
rankings of the OMs per section and ICF domain and details
of the OMs, such as clinimetric properties with references and
measurement protocols, can be found in the online supplement
(Tables S1–S3, S6–S8, respectively).
Measurement Time Points
In round 2, between three and eightmeasurement time points per
OM within ICF domains were proposed by the experts showing
consistent agreement in a range from 48 to 90%. Agreement
rates for measurements at 6, 10, 12, and 20 weeks were below
50 ± 2% and were not presented in the last round. Because
of expert comments, the first two time points were combined
and presented in the final round as one measurement to be
administered within the first 3 days. Final agreement was given,
with agreement rates ranging from 65.2 to 91.3% for a maximum
of seven measurement time points for the upper and lower
extremity body functions domain to be taken between days 1
and 3; at day 7; at weeks 2, 4, and 12; at 6 months; and every
following 6th month. In the activities domain of the upper and
lower extremity sections, agreement of measurement time points
followed the same scheme but starting at day 7. A deviating
schemewas compiled for the ADL/stroke-specific OMs (Table 3).
Final agreement rates can be found in the online supplement
(Tables S4, S5).
DISCUSSION
The goal of this Delphi study was to develop a core set of
OMs for clinical motor rehabilitation after stroke as a tool to
evaluate the quality of stroke rehabilitation at a local, national,
and international level. The consensus-based core set contains
nine OMs that cover a wide range of measurement constructs
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FIGURE 2 | Flowchart of outcome measures per Delphi round, section, and ICF domain. ADL, activities of daily living; ICF, International Classification of Functioning,
Disability, and Health; OMs, outcome measures.
within all ICF domains that are applicable to patients with
different stroke severity levels. In addition, a framework with
fixed measurement time points was established, following a non-
linear pattern (33), with more frequent measurements within the
first 3 months after stroke and larger measurement intervals in
the chronic phase. The core set was developed on the basis of
independent opinions of international experts of different health
care professions. All experts have comprehensive experience in
clinical stroke rehabilitation. This active involvement of clinical
stakeholders ensures the set’s clinical relevance, feasibility,
and applicability.
Core Set for Clinical Motor Rehabilitation
After Stroke
The FMA-UE and ARAT are the selected OMs for the
upper extremity section and are in line with the minimal
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TABLE 2 | Core set of outcome measures for clinical motor rehabilitation after
stroke.
ADL, activities of daily living; ICF, International Classification of Functioning, Disability,
and Health.
*Measure only required for patients with a Functional Ambulation Categories score
of ≥3/5.
set developed for stroke rehabilitation trials (10). Both
instruments have excellent clinimetric properties and therefore
demonstrate a high measurement quality for clinical stroke
rehabilitation (6, 11). In order to guarantee consistent
measurements that allow comparing clinical and research
findings, standardized measurement procedures should
be followed.
The lower extremity section of the core set covers a
large variety of constructs within the spectrum of body
functions and activities: motor function, gait speed, functional
mobility, and balance in sitting and standing. The OMs are
feasible and relevant for stroke patients with and without
walking ability. Outcome measures on the activities domain
are discriminated by the Functional Ambulation Categories
(FAC). Hence, the FAC is not per se included as one of the
core set’s OMs, but it is a screening tool to determine which
OMs should at least be applied. The constructs of motor
function (FMA-LE) and balance (BBS) should be evaluated in
all patients, whereas walking speed (10 MWT) and functional
mobility (TUG) should only be assessed in patients with an
FAC score of at least three out of five. Comparing these
OMs for the lower extremity with those recommended for
stroke rehabilitation research (10) clearly shows that although
the constructs of functional balance and mobility were not
recommended for research, they are found to be relevant for the
clinical setting.
The ADLs/stroke-specific OMs section covers the constructs
stroke severity (body functions domain) and basic ADLs
(activities domain). Within the activities domain, the
highest rank is shared by the BI and FIM, which are
highly correlated (r = 0.92–0.99) (34). These OMs can
be chosen upon individual considerations within stroke
services. The FIM requires annual license fees and provides
chargeable access to training materials, offers data services,
and contains additional socio-cognitive items. The BI might
be favorable regarding time and financial resources (online
supplement, Table S8).
The majority of the recommended OMs are designed to
objectify the patient’s observed functional impairment or to
evaluate motor capacity in a standardized test environment,
which is defined as the “maximum potential of an individual
to succeed in the performance of a motor skill” (35). The
included capacity measures are complemented by the patient-
reported SIS, which is sensitive to change (36). The SIS
not only covers the participation domain of the ICF, but
also provides the patient’s perspective on the body functions
and activities domain. With that, it adds an important
multidomain perspective to this clinical core set, a perspective
on which no consensus was found for stroke rehabilitation
research (10).
The core set’s OMs are part of the few clinical guidelines that
gave specific recommendations on OMs (9), which potentially
facilitates implementation at a national level. The responsibility
of clinical assessments should be shared by the involved
health care professions according to their specialization. The
total time to complete the core set lies between 60 and
75min, depending on the patient’s ability to understand and
answer questions or to perform the required tasks of the BI
or FIM.
Measurement Time Points
The core set provides a refined framework of fixed measurement
time points poststroke, with more frequent measurements
early after symptom onset and a low frequent monitoring
pattern in the chronic phase. This is in accordance with
the logarithmic pattern of sensorimotor recovery after stroke,
in which the greatest changes on the body functions and
activities domains occur within the first 12 weeks after symptom
onset (37, 38). In this period, behavioral restitution takes
place, and thereafter, changes occur predominantly due to
compensational mechanisms, reaching a plateau between ∼3
and 6 months poststroke (33). Low-frequent assessment in the
chronic phase allows for monitoring the patient’s impairments
and disabilities. In case of presence or lack of clinically relevant
changes, rehabilitation can be restarted, continued, adapted, or
completed (29).
The core set’s seven consensus-based measurement time
points are in line with existing recommendations in national
clinical guidelines (29, 39) and stroke rehabilitation research
guidelines (10) to assess in all four recovery phases poststroke
(40). However, the experts recommended more measurement
time points in the subacute phase, when compared to research
recommendations. This will provide more detail about the
individual motor recovery pattern across different ICF domains
and therefore promote personalized rehabilitation and support
appropriate discharge and adaptive planning regarding the
home environment. The experts did not select admission and
discharge as recommended measurement time points. Although
we did not investigate the reason for not selecting specific
time points by the experts, we hypothesize that this could
be explained by the large international variability in both
the length of stay and the accessibility to acute clinics and
rehabilitation facilities (41). These arbitrary time points impede
the comparability on a regional, national, and international
level. As the consensus-based time points are a minimum
number of required measurement time points, measurements
at admission and discharge could be optionally implemented
in the local framework to facilitate rehabilitation goal setting
and evaluation.
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TABLE 3 | Measurement time points of the core set for clinical motor rehabilitation after stroke.
X, recommended time point for assessment; d, day; m, month; wk, week; (1) exceptional time points for the National Institutes of Health Stroke Scale, only indicated at these time
points; (2) exceptional time points for the Barthel Index/Functional Independence Measure, only indicated at these time points.
For clinical practice, an important clinimetric requirement of
OMs is their responsiveness to clinically meaningful differences.
As it is known that these differences depend on the recovery
phase poststroke (42), changes between measurements should be
related to the poststroke phase-specific MCID. Although results
of anchor-based MCIDs were no inclusion criterion for the
preselection of OMs in the Delphi study, MCIDs are available
from the acute to the chronic stage for most OMs (online
supplement Tables S6–S8).
The experts’ consensus resulted in a clear measurement
pattern for upper and lower extremity body functions and
activities. They proposed a scheme with less measurement time
points for the ADL/stroke specific section, possibly because these
OMs are not valid and responsive at all time points.
Limitations
There are considerations to be made regarding the developed
core set for clinical motor rehabilitation after stroke. First, the
availability of validated translations and transcultural validations
was no inclusion criterion for OMs. However, with the call
for international quality standards in stroke care (3), it should
be the interest of stroke services on a regional and national
level, to allow for translated and validated versions of the
core set’s OMs. Second, although we aimed for a well-
balanced group of experts in terms of clinical background,
occupational therapists were underrepresented. It is unlikely that
this influenced the final core set, as there were only marginal
variations in the rankings between professions. Regarding the
balance by regions of practice, Eastern European countries were
underrepresented. Third, there is variability in agreement rates
of measurement time points after rounds 2 and 3. However,
there was a clear difference in agreement rates between the
excluded and final recommended measurement time points.
Finally, although most of the experts are still clinically active in
stroke rehabilitation, many of them are also involved in research,
and they may have ranked OMs using both their clinical and
research experiences.
Future Directions
In a next step, the core set for clinical motor rehabilitation
after stroke should be implemented across the whole stroke
care pathway, including stroke units and acute hospitals,
rehabilitation facilities, and outpatient centers or private
practices. It should be acknowledged that the implementation
of standardized tests in the clinic is challenging. Bland and
colleagues (43) demonstrated differences in adherence between
settings and professions. Especially in the outpatient facilities,
standardized assessments were less frequently applied. However,
implementation projects have demonstrated that educational
programs and assessment training leads to a successful
implementation of stroke OMs in clinical practice (44), and
these should be taken as a good example. Routinely scheduled
time slots for fixed measurement time points could support time
and resource efficiency. A reevaluation of the core set’s OMs
and the adherence of health care professionals to apply this set
should be initiated in 5 years. The measurements’ results should
be fed to national registries to gain insight into the quality of
clinical motor rehabilitation in the acute, subacute, and chronic
phase poststroke and provide input for actions for improvement.
Last but not least, a collaboration of clinicians and researchers
should aim for the development of a minimal set of OMs for
other important domains in clinical stroke rehabilitation, such as
cognition and speech.
CONCLUSION
The consensus-based core set of OMs for clinical motor
rehabilitation after stroke contains nine OMs that cover the main
impairments in body functions, activities, and participation on
the motor domain and is complementary to recommendations
for stroke rehabilitation research. Measurements should be
performed at six time points within the first 6 months poststroke,
and consecutivemonitoring should take place every 6thmonth in
the chronic stage. The core set and its measurement framework
should be implemented throughout the whole stroke care
continuum and allows benchmarking, with the long-term goal to
optimize the quality of poststroke rehabilitation.
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